Larixinol

CAS : 101046-79-1

Ref. 3D-BEA04679

Informations sur le produit

• Nom: Larixinol
• Synonymes: Spiro[benzofuran-3(2H),9'(8'H)-[2H]furo[2,3-h][1]benzopyran]-8'-one,3',4'-dihydro-3',4,5',6-tetrahydroxy-2,2'-bis(4-hydroxyphenyl)-, [2'R-[2'a,3'a,9'b(R*)]]-, 2''-epi-Abiesinol F, Abiesinol E, Listvenol
• CAS: 101046-79-1

Description

Larixinol is a polyphenolic compound that has been extracted from Larix occidentalis bark. It has potent antibacterial activity against Gram-positive and Gram-negative bacteria, including methicillin-resistant Staphylococcus aureus (MRSA). Larixinol is also the major active constituent of decidua, which is the tissue that covers the fetus during pregnancy. The chemical structures of larixinol include procyanidins, which are oligomeric proanthocyanidins with potent inhibitory activities. Larixinol inhibits fatty acid synthesis and cox-2 activity in vitro, and it has also been shown to have potential use as an anti-inflammatory drug. This compound can be used to prepare a high-efficient preparative high performance liquid chromatography (HPLC) method for larixinol analysis. The enzymatic reaction between larixinol and myeloperoxidase leads to the production of

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 542.5 g/mol
• Formule: C₃₀H₂₂O₁₀
• Degré de pureté: Min. 95%